U.S. federal trademark · Serial No. 88199609
pharmaceutical preparation for the treatment of cancer, namely, to reverse a patient's resistance to other drugs used in the treatment of cancer; pharmaceutical preparations for use in the treatment of multi-drug resistant diseases, cancer, infectious diseases, malaria, tuberculosis, leishmania, aids, trypanosomiasis and amoebic dysentery
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.